Bertelsmann Investments reports a 46.3% revenue increase in H1 2024, emphasizing its strategic investments in high-growth sectors, particularly digital health and pharma tech.

Information on the Target

Bertelsmann Investments (BI) has reported a significant increase in its revenues for the first half of 2024, reaching €300 million, which marks a 46.3% growth from €205 million in the same period last year. The company's adjusted operating EBITDA also saw noteworthy improvement, climbing to €30 million from just €7 million in H1 2023. BI achieved 15 new and 15 follow-on investments through its four venture capital funds and the Bertelsmann Next unit, demonstrating its active engagement in the investment landscape with a total of 374 active investments worldwide.

Among its key ventures, the mobile ad tech company Applike reported an impressive organic growth of 154%. Additionally, the recent acquisition of Extedo, a leader in software solutions for regulatory information management in the pharma tech sector, signifies Bertelsmann's strategic focus on expanding its capabilities in both the digital health and pharma tech industries.

Industry Overview in the Target’s Specific Country

In recent years, Germany's venture capital landscape has witnessed robust growth, especially in sectors such as digital health, HR tech, and mobile advertising technologies. The increasing demand for innovative solutions in healthcare, driven by d